Yostra Labs develops point-of-care diagnostic and wound-care devices aimed at managing major chronic diseases, notably diabetic foot complications. Its flagship products are NEURO TOUCH, a screening device for peripheral neuropathy, and VELOX Care, an advanced wound care solution for chronic wounds including diabetic foot ulcers. The company says it has screened over 40,000 patients across clinics, hospitals, and diagnostic centers in India. Yostra was founded in 2014 and is using its seed financing to commercialize its product portfolio and scale production. With the new funds it plans to hire additional sales and marketing talent, optimize its bill of materials, and expand market reach. The startup positions its technology as addressing a widely neglected complication of diabetes that the article states carries mortality higher than many cancers.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2022